第一单位：
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Institute for Chemical Immunology, Nijmegen 6525 GA, Netherlands.
作者：
Jorieke,Weiden [1]
;
Marjolein,Schluck [1]
;
Melina,Ioannidis [2]
;
Eric A W,van Dinther [3]
;
Mahboobeh,Rezaeeyazdi [4]
;
Fawad,Omar [2]
;
Juulke,Steuten [2]
;
Dion,Voerman [1]
;
Jurjen,Tel [5]
;
Mustafa,Diken [6]
;
Sidi A,Bencherif [7]
;
Carl G,Figdor [1]
;
Martijn,Verdoes [8]
作者单位：
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Institute for Chemical Immunology, Nijmegen 6525 GA, Netherlands.
[1]
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.
[2]
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.
[3]
Department of Chemical Engineering, Northeastern University, Boston, Massachusetts 02115, United States.
[4]
Department of Biomedical Engineering, Laboratory of Immunoengineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven 5600 MB, Netherlands.
[5]
TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz 55131, Germany.
[6]
Department of Chemical Engineering, Northeastern University, Boston, Massachusetts 02115, United States.;Department of Bioengineering, Northeastern University, Boston, Massachusetts 02115, United States.;Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, United States.;Biomechanics and Bioengineering (BMBI), UTC CNRS UMR 7338, University of Technology of Compiègne, Sorbonne University, Compiègne 60203, France.
[7]
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands.;Institute for Chemical Immunology, Nijmegen 6525 GA, Netherlands.
[8]
DOI
10.1021/acsbiomaterials.0c01648
PMID
34734689
发布时间
2024-04-04
换一批
